Figure 7From: Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysisEffect of LAM + ADV vs . ETV on virologic breakthrough 48 weeks post treatment.Back to article page